🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Celebrating #BlackHistoryMonth by recognizing the work of Dr. Ashley Spann with AI, predictive modeling, and innovative EHR strategies. Dr. Spann is revolutionizing #liverdisease care and shaping the future of medical informatics.

Enjoyed catching up with old friends/former trainees and being the keynote speaker today for the 11th annual The Ohio State University Wexner Medical Center #OSUGHNDivision Hepatology symposium and speaking about AI in Hepatology

There are different clusters of people with #MASLD, partially explaining the heterogeneity in pathophysiology and clinical outcomes. nature.com/articles/s4157…

Richard Peek, MD, director of the Division of Gastroenterology, Hepatology and Nutrition, has been elected vice president of the American Gastroenterological Association (AGA), the specialty’s primary and most influential international organization. Congratulations, Dr. Peek! news.vumc.org/2025/03/07/ric…

Rationale and Design of NUDGE-CKD: A Nationwide Randomized Factorial Trial of Electronic Nudges for Increasing Guideline-Directed Medical Therapy in Chronic Kidney Disease From Tor Biering-Sørensen, MD, MSc, MPH, PhD and team: sciencedirect.com/science/articl…

Excellent work by Dr. Richardson on this important work presented at #DDW2025

Excellent paper shedding some light into this emerging field #LiverX #MetALD

Enjoyed giving this talk today EASL Education on ethical deployment of AI for liver disease! #EASLCongress

Seminar from the EASLnews AI Taskforce at 15:00 in Hepatology Arena. 'Integrating AI Large Language Models into Liver Disease Care' This session has something for everybody - AI experts, clinicians, young investigators, & pathologists. Great speakers & dynamic discussions✅

🤖#AI & #LLMs are reshaping hepatology, from smarter workflows to empowered patients In the Hepatology Arena we're learning how these tools can trasnform liver care, research and real-time decisions. @EASLNews #EASLcongress #LiverX #AI

EASLnews Ashley Spann Tom Marjot Tom Luedde From FIB-4 to future-ready care: Ashley Spann is sharing how #AI tools embedded in EHRs boosted clinical action from 30% to 46% 📈 💡LLMs, chatbots, & eCDSS are reshaping liver care leading to faster, smarter decisions. EASLnews #EASLcongress #LiverX

EASLnews Ashley Spann Tom Marjot Tom Luedde So what are #LLMs? 🤔 👉#AI tools trained to understand and generate human language. They can be used to supporte clinicians, researchers, and patients with tasks like summarisation, decision-making, and chatbots. EASLnews #EASLcongress #LiverX

EASLnews Ashley Spann Tom Marjot Tom Luedde In hepatology, #ChatGPT has been investigated to answer liver-related clinical questions. Although it showed strong accuracy: 😲Only ~47% of #cirrhosis & 41% of #HCC answers are comprehensive. ⚠️Powerful, yes, but "hallucinations", outdated data (last trained Dec 2023), and

EASLnews Ashley Spann Tom Marjot Tom Luedde LLMs like #ChatGPT4 show high accuracy (87.5%) in grading #MASLD histology from pathology images. EASLnews #EASLcongress #LiverX

EASLnews Ashley Spann Tom Marjot Tom Luedde ChatGPT-4 shows strong potential in liver pathology: ✅ Accurately stages #MASH fibrosis, outperforming pathologists when given context ✅ 81% diagnostic accuracy ⚠️ Still limited by lack of FOV-awareness, hallucinations & outdated training #AI tools already assist us in our

EASLnews Ashley Spann Tom Marjot Tom Luedde 😲60% of people struggle with health literacy, not due to language, but info overload & poor quality. 🫂Trust remains a key issue: people frequently turn to the internet over healthcare providers for answers, especially in younger age groups. ⛰️The major challenge is ensuring

EASLnews Ashley Spann Tom Marjot Tom Luedde In hepatology, how should we assess AI tools like ChatGPT? 🧑‍⚕️Clinicians focus on accuracy, context & regulation. 🧑‍🦱Patients are more open, using AI for second opinions, clarity, & reassurance. ⚠️But beware: AI may lack precision, context awareness & over-recommend imaging.

After 🔟 years, the new EASLnews CPG on AutoImmune Hepatitis are here! 👉bit.ly/3F372Sf Liver biopsy 🔬 remains a pillar for diagnosis🎯! Congratulations to the author team 🇬🇷 🇳🇱🇬🇧 🇩🇰 🇩🇪🇪🇸🇮🇹🇭🇺 &EASL European Society of Pathology (ESP) my_UEG HASL UK Liver Pathology Group Hans Popper Hepatopathology Society

The latest #EASLDeepDive on #TIPS in #MASLD is now available on demand! Learn how to identify suitable candidates, navigate cardiopulmonary risks, and address post-TIPS encephalopathy. 🔗easlcampus.eu/webinars/easl-… @EASLNews #LiverX

In next week's episode, Ahmed Elsharkawy Jakob Nikolas Kather Sabela Lens García Ashley Spann will talk about Artificial Intelligence: 🤔 "Is This the Beginning of the End of the Medical Profession as We Know It?" 📅 Save the date! Wednesday, 4 June 2025, 18:00 CEST 👉🏽 easl.eu/easl-studio-ep…